Despite promising Phase 3 results, safety concerns, namely liver injury, have impacted Agios stock and could affect Pyrukund's approval and market adoption. Read the full report here.
Using a series of more than 1,000 X-ray snapshots of the shapeshifting of enzymes in action, researchers at Stanford ...
Using a series of more than 1,000 X-ray snapshots of the shapeshifting of enzymes in action, researchers at Stanford ...
An enzyme called cyclin-dependent kinase 2 (CDK2) regulates the cell cycle and may have the potential to drive therapeutic ...
Growing interest in Nitric Boost Ultra often leads prospective customers to ask about costs, authenticity, and shipping ...
Unfortunately, there isn't an enzyme for many reactions we would sorely like to catalyze—things like digesting plastics or ...
Given that alcohol is the most frequent functional group found in bioactive natural products and marketed drugs, and is a ...
New research uses AI to engineer enzymes with intricate active sites, expanding the possibilities for synthetic biocatalysts.
New research represents a notable step forward in designing enzymes from scratch. With their approach, the authors designed an enzyme that uses a ...
Enzymes are proteins – large molecules that do the behind-the-scenes work that keep all living things alive. These proteins are made up of amino acids, a set of building blocks that can be stitched ...
Researchers at the Harvard Medical School discovered that the enzyme GUK1 promotes lung cancer growth by boosting the ...
New research represents a notable step forward in designing enzymes from scratch. With their approach, the authors designed an enzyme that uses a covalent intermediate to catalyze a two-step reaction, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results